OBJECTIVES This study evaluated the efficacy of long-term treatment with the angiotensin-
converting enzyme (ACE) inhibitor trandolapril in diabetic patients with left ventricular …

Background Treatment with angiotensin-converting–enzyme (ACE) inhibitors reduces
mortality among survivors of acute myocardial infarction, but whether to use ACE inhibitors …

To study the importance of giving an angiotensin-converting enzyme (ACE) inhibitor to
patients with reduced systolic function after an infarction, the Trandodolapril Cardiac …

Background Mortality of diabetic patients with acute myocardial infarction (MI) remains high
despite recent improvement in their management. There is a need to evaluate efficacy and …

Aims To investigate the long-term benefits of treatment with angiotensin-converting enzyme
(ACE)-inhibitors in patients with myocardial infarction (MI) and left ventricular dysfunction …

Objective To evaluate the influence of a history of arterial hypertension on the efficacy of the
angiotensin converting enzyme (ACE) inhibitor trandolapril in patients with acute myocardial …

Abstract The TRAndolapril Cardiac Evaluation (TRACE) study is evaluating the effect of
angiotensin-converting enzyme inhibition with trandolapril on mortality (overall and …

Angiotensin-converting enzyme (ACE) inhibitors improve survival in patients with congestive
heart failure (CHF) after an acute myocardial infarction (AMI), but mortality may be as high as …

Aims/hypothesis. Mortality of diabetic patients after myocardial infarction remains high
despite recent improvement in their management. This study population-based evaluates …

A variety of disciplines including noninvasive and invasive cardiac methodologies, as well
as epidemiologic studies, have provided information that has altered our view on the relation …